nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—AR—scrotum—penile cancer	0.566	0.566	CbGeAlD
Enzalutamide—AR—penis—penile cancer	0.255	0.255	CbGeAlD
Enzalutamide—AR—skin of body—penile cancer	0.0426	0.0426	CbGeAlD
Enzalutamide—AR—urethra—penile cancer	0.0408	0.0408	CbGeAlD
Enzalutamide—CYP2B6—skin of body—penile cancer	0.0309	0.0309	CbGeAlD
Enzalutamide—ALB—lymph node—penile cancer	0.0224	0.0224	CbGeAlD
Enzalutamide—AR—lymph node—penile cancer	0.0195	0.0195	CbGeAlD
Enzalutamide—ABCB1—urethra—penile cancer	0.0158	0.0158	CbGeAlD
Enzalutamide—ABCB1—lymph node—penile cancer	0.00755	0.00755	CbGeAlD
